Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Bristol, TN
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Bristol, TN
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Arlington, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Dallas, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
El Paso, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
McKinney, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
McKinney, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Clinton, UT
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Clinton, UT
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Bellingham, WA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Bellingham, WA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Research Site
mi
from
New Lambton,
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Research Site
mi
from
New Lambton,
Click here to add this to my saved trials
Antioxidant Therapy in Lean and Obese Asthmatics
Phase 2 Study of Antioxidant Therapy in Lean and Obese Asthmatics
Status: Enrolling
Updated:  3/21/2016
Nemours Children's Clinic
mi
from
Jacksonville, FL
Antioxidant Therapy in Lean and Obese Asthmatics
Phase 2 Study of Antioxidant Therapy in Lean and Obese Asthmatics
Status: Enrolling
Updated: 3/21/2016
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing
Status: Enrolling
Updated:  3/22/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing
Status: Enrolling
Updated: 3/22/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Status: Enrolling
Updated:  3/23/2016
National Jewish Health
mi
from
Denver, CO
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Status: Enrolling
Updated: 3/23/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
Status: Enrolling
Updated:  3/30/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
Status: Enrolling
Updated: 3/30/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Status: Enrolling
Updated:  3/31/2016
Asthma Research Center
mi
from
Boston, MA
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Status: Enrolling
Updated: 3/31/2016
Asthma Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Little Rock, AR
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Fresno, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Riverside, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Rolling Hills Estates, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
San Diego, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Upland, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Upland, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Tallahassee, FL
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Owensboro, KY
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Baltimore, MD
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Columbia, MD
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Columbia, MD
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Minneapolis, MN
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Plymouth, MN
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Corning, NY
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Corning, NY
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Charlotte, NC
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Shelby, NC
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Shelby, NC
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Medford, OR
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Greenville, SC
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
mi
from
Coffs Harbour,
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
mi
from
Coffs Harbour,
Click here to add this to my saved trials
Flexibility and Strength Training in Asthma
FASTA: Flexibility and Strength Training in Asthma
Status: Enrolling
Updated:  3/31/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Flexibility and Strength Training in Asthma
FASTA: Flexibility and Strength Training in Asthma
Status: Enrolling
Updated: 3/31/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Hoover, AL
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Hoover, AL
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Montgomery, AL
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Gilbert, AZ
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Little Rock, AR
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Huntington Beach, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Long Beach, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Mission Viejo, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Newport Beach, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Ontario, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Ontario, CA
Click here to add this to my saved trials